Breaking News
Subscribe Now 0
Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 place See list
Close

Cardiff Oncology Inc (CRDF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Cardiff Oncology's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.630 +0.110    +4.37%
11/10 - Closed. Currency in USD ( Disclaimer )
After Hours
2.630
-0.000
-0.000%
16:18:39 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 421,054
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 2.500 - 2.640
Cardiff Oncology 2.630 +0.110 +4.37%

CRDF Interactive Chart

 
Get instant access to a free live interactive chart for the Cardiff Oncology Inc stock. You have the option to change the appearance of the charts by varying the time scale, chart type, zooming in to different sections and adding new studies or indicators such as RSI, MACD, EMA, Bollinger Bands, Fibonacci retracements and many more. You can save your Cardiff Oncology stock studies and create your own systems as well as having the option to set the colors of each object on the chart.
Sign In / Free Sign Up now to save your chart settings.
press ESC to exit fullscreen mode
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CRDF Comments

Write your thoughts about Cardiff Oncology Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ace Geo
Ace Geo Mar 01, 2024 1:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Regardless of how this operates in the short term, it's still very undervalued.
MIKHAIL KUZNETSOV
MIKHAIL KUZNETSOV Jan 30, 2022 7:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I really like this failure, I bought it for $ 3, I hope it will fly into the stratosphere soon!!!
criptomonedas ripple cardano
criptomonedas ripple cardano Dec 03, 2021 1:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
cardiff 100$
Joe Montana
Joe Montana Apr 26, 2021 10:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
about to pop
Shahan Khan
Shahan Khan Mar 08, 2021 7:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
11.20 soon
Dee Trinbagonian
Dee Trinbagonian Feb 27, 2021 3:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
To the moon 🚀
Jobir Avezov
Jobir Avezov Feb 02, 2021 1:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Wow its going to gain sooner
Aktieris Vanjaa
Aktieris Vanjaa Jan 24, 2021 12:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Zman Any tips for bull?
Zman Trading
ZmanTrading Jan 24, 2021 12:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Setting SL $10.18 and still my short term target is $14.
Zman Trading
ZmanTrading Jan 24, 2021 12:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Zman Trading Don’t look right. Sold with loss at $10,34. Good luck to those who still hang on!
Jobir Avezov
Jobir Avezov Jan 24, 2021 12:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Zman Trading No hopes mate
Aaron Strong
Aaron Strong Jan 24, 2021 12:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Zman Trading good call👎
Ahmad AL-s
Ahmad AL-s Jan 24, 2021 12:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Zman Trading  i think its a good buy now
Zman Trading
ZmanTrading Jan 24, 2021 11:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://seekingalpha.com/article/4400581-first-look-cardiff-oncology
Zman Trading
ZmanTrading Jan 21, 2021 4:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
In green! Very important step in the right direction. Price is at +11.45% from yesterdays low!
Zman Trading
ZmanTrading Jan 21, 2021 4:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Higher high and higher low on the daily!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email